Long intergenic non-protein coding RNA 3033 (LINC03033)

Long intergenic non-protein coding RNA 3033 (LINC03033, also known as FLJ22447 or lncRNA-CAF) is a long noncoding RNA identified as specifically upregulated in cancer-associated fibroblasts (CAFs)[2][4]. It plays a central role in the activation and function of CAFs, controlling gene expression and cellular signaling that modulate the tumor microenvironment. LINC03033 has been implicated in promoting tumor growth, metastasis, immune escape, and therapy resistance by enhancing the crosstalk between cancer cells and stromal cells. Its regulatory mechanisms include modulation of cytokine secretion, exosome-mediated cell communication, and interactions with various biomolecules at the transcriptional, post-transcriptional, and epigenetic levels. While its biological significance in cancer development and progression is established, it has not yet been translated into a direct therapeutic target or druggable entity, but may serve as a biomarker or research target for anti-cancer strategies focused on the tumor microenvironment[1][2][4].

Other names

LncRNA-CAFFLJ22447lncRNA Cancer-associated fibroblastLINC03033

Not applicable. LINC03033 is not the direct target of any approved drugs, but it acts as a regulatory RNA influencing cancer biology—potential mechanisms involve: - Upregulation of cytokines (e.g., IL-33 modulation by FLJ22447/LINC03033 in oral squamous cell carcinoma) - Epigenetic, transcriptional, and post-transcriptional gene regulation in cancer stromal cells